We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
For the first time in 75 years, Bayer could operate in the US under its own name and using its own Bayer Cross corporate logo ... pharmaceuticals In 2014, Bayer completed the acquisition of the ...
Investors in Swiss pharmaceuticals firm Roche (RHHBY) were left nursing a headache today as its stock dropped on plans to ...
Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...
Swiss pharmaceutical giant Roche is cutting its global diversity workforce targets, aligning with recent U.S. legal changes ...
Kepler Capital analyst David Evans maintained a Buy rating on Roche Holding AG (RHHVF – Research Report) on March 17 and set a price target of ...
FRANKFURT (Reuters) -Swiss drugmaker Roche has abandoned global targets for a more diverse workforce to avoid penalties from ...
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...
8h
News-Medical.Net on MSNExperimental drug shows promise in reducing risk of Alzheimer's-related dementiaAn experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...
Bill Anderson's replacement as chief executive of Roche Pharmaceuticals has been announced, with head of global product strategy Teresa Graham stepping up into the role. Anderson's departure was ...
Roche Holding AG scrapped long-held global diversity targets for its leadership, showing how pressure from the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results